Panagora Asset Management Inc Eagle Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$17.74 - $31.87 $217,882 - $391,427	12,282 New	12,282 $238,000
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $103,619 - $184,804	3,922 Added 55.32%	11,012 $291,000
Q3 2021 Nov 10, 2021	SELL	$43.79 - $55.78 $391,132 - $498,226	-8,932 Reduced 55.75%	7,090 $395,000
Q2 2021 Aug 11, 2021	BUY	$36.86 - $44.5 $579,918 - $700,118	15,733 Added 5443.94%	16,022 $686,000
Q1 2021 May 12, 2021	SELL	$40.32 - $50.97 $553,835 - $700,123	-13,736 Reduced 97.94%	289 $12,000
Q3 2020 Nov 13, 2020	SELL	$37.02 - $51.28 $18,213 - $25,229	-492 Reduced 3.39%	14,025 $596,000
Q2 2020 Aug 12, 2020	SELL	$43.24 - $55.02 $1.16 Million - $1.48 Million	-26,873 Reduced 64.93%	14,517 $697,000
Q1 2020 May 14, 2020	SELL	$34.37 - $60.07 $2.3 Million - $4.03 Million	-67,024 Reduced 61.82%	41,390 $1.9 Million
Q4 2019 Feb 12, 2020	BUY	$54.32 - $64.31 $715,285 - $846,834	13,168 Added 13.83%	108,414 $6.51 Million
Q3 2019 Nov 12, 2019	SELL	$53.25 - $59.98 $170,240 - $191,756	-3,197 Reduced 3.25%	95,246 $5.39 Million
Q2 2019 Aug 09, 2019	SELL	$46.61 - $58.45 $867,039 - $1.09 Million	-18,602 Reduced 15.89%	98,443 $5.48 Million
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $1.95 Million - $2.61 Million	50,314 Added 75.4%	117,045 $5.91 Million
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $279,475 - $515,493	7,611 Added 12.87%	66,731 $2.69 Million
Q3 2018 Nov 13, 2018	BUY	$66.65 - $83.86 $1.16 Million - $1.46 Million	17,441 Added 41.85%	59,120 $4.1 Million
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $2.14 Million - $3.19 Million	41,679 New	41,679 $3.15 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account